<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K799DP4&l=dataLayer" height="0" width="0" style="display:none;visibility:hidden"></iframe>
NAS:BOLD (USA) Also Trade In: Germany

Audentes Therapeutics Inc $ 27.29 -0.87 (-3.09%)

Volume:
182,159
Avg Vol (1m):
418,827
Market Cap $:
1.25 Bil
Enterprise Value $:
901.71 Mil
P/E (TTM):
0.00
P/B:
2.93
Warning! GuruFocus has detected 2 Severe warning signs with BOLD. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

Financial Strength

6.4/10
Current Vs Industry Vs History
Cash-To-Debt 12.34
Debt-to-Equity 0.07
Debt-to-EBITDA -0.19
N/A
Piotroski F-Score 2
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
ROIC -404.49 %
WACC 12.92 %

Profitability

2/10
Current Vs Industry Vs History
ROE % -43.33
ROA % -39.35
ROC (Joel Greenblatt) % -412.98
3-Year EBITDA Growth Rate -27
3-Year EPS without NRI Growth Rate -14.2

Ratios

Current Vs Industry Vs History
PB Ratio 2.93
EV-to-EBIT -5.16
N/A
EV-to-EBITDA -5.42
N/A
Current Ratio 14.38
Quick Ratio 14.38

Dividend & Buy Back

Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -33.3

Valuation & Return

Current Vs Industry Vs History
Price-to-Tangible-Book 3
Earnings Yield (Greenblatt) % -19.33